Delve into the evolving landscape of neuroimaging in functional neurological disorders and discover the cutting-edge research that’s reshaping our understanding of this complex field.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
A Case of Extremely Rapid Progression in Foix-Alajouanine Syndrome.
Hubbard et al., World Neurosurg 2024
DOI: 10.1016/j.wneu.2024.01.152
Oh, the elusive Foix-Alajouanine Syndrome, a condition so rare it’s practically a unicorn in the world of spinal dural arteriovenous fistulas. But don’t let its rarity fool you; this bad boy can turn your spinal cord into a non-functioning noodle faster than you can say “irreversible myelopathy.” And guess what? Despite doctors playing medical detective with a plethora of tests, this sneaky syndrome still manages to slip through the cracks. Shocking, I know.
Case in point: a 68-year-old who became the poster child for “classic symptoms” of this condition, with their health going downhill faster than a skier on a black diamond slope. Less than a year, and boom, severe myelopathy. The cavalry arrived in the form of endovascular intervention, but alas, it was too little, too late. Our patient’s neurological recovery was a no-show.
The moral of the story? If you don’t want to miss the Foix-Alajouanine boat, better throw in some snazzy spinal imaging early on in the game. Because, you know, it might just prevent your patients from being permanently parked in a wheelchair. Just a thought.
